logo

For the Inventor, By the Inventor

Toyonaka, Japan

Yasushi Shintani

This inventor holds 18 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Takeda Chemical Industries, Inc., Takeda Pharmaceuticals U.s.a., Inc.. Active years: 1999-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasushi Shintani. Retrieved from https://idiyas.com/inventor/yasushi-shintani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 27.8

 

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 79(Granted Patents)


Location History:

  • Tsukuba, JP (1999 - 2003)
  • Toyonaka, JP (2006 - 2008)
  • Ibaraki, JP (2001 - 2009)
  • Hamburg, DE (2007 - 2010)
  • Osaka, JP (2011 - 2014)

Company Filing History:

goldMedal10 out of 1,226 
 
Takeda Pharmaceutical Company Limited
 patents
silverMedal7 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
bronzeMedal1 out of 24 
 
Takeda Pharmaceuticals U.s.a., Inc.
 patents

Years Active: 1999-2014

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents
1. 8785491 - Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues (2014-07-22),
2. 7998684 - Screening method for an agent for treatment of neurodegenerative disease (2011-08-16),
3. 7662574 - Use of a G protein-coupled receptor and its cognizant ligand in the identification of compounds that affect prolactin secretion (2010-02-16),
4. 7608409 - Screening assay using G-protein coupled receptor protein OT7T175 (2009-10-27),
5. 7419956 - Isolated physiologically active peptide and use thereof (2008-09-02),
6. 7314754 - Polynucleotide encoding the hOT7T175 G protein coupled receptor (2008-01-01),
7. 7273710 - Method for screening MCH receptor antagonist/agonist (2007-09-25),
8. 7250272 - G protein-coupled receptor protein and DNA thereof (2007-07-31),
9. 7192723 - G protein-coupled receptor protein, its DNA and ligand thereof (2007-03-20),
10. 7138249 - Screening method (2006-11-21),
11. 7045299 - Physiologically active peptide and use thereof (2006-05-16),
12. 6699965 - Peptides that activate the G-protein coupled receptor protein, 0T7T175 (2004-03-02),
13. 6632627 - Glutamine: fructose-6-phosphate amidotransferase, its production and use (2003-10-14),
14. 6590090 - Fas ligand-like protein, its production and use (2003-07-08),
15. 6235878 - Fas ligand-like protein, its production and use (2001-05-22),

Title: **Yasushi Shintani: Innovator in Pharmaceutical Research**

Introduction

Yasushi Shintani is a prominent inventor based in Toyonaka, Japan. With a substantial portfolio of 18 patents, he has made significant contributions to the field of pharmaceutical research, particularly in treatments for age-related diseases.

Latest Patents

Among his latest innovations, Shintani has developed pharmaceutical compositions and methods for treating age-related macular degeneration using melatonin analogues. This work aims to provide effective solutions for this debilitating condition. Additionally, he has created a screening method for agents targeting neurodegenerative diseases. This involves compounds that promote the ubiquitination and degradation of specific proteins, which may lead to advancements in therapeutic strategies for neurodegenerative conditions.

Career Highlights

Throughout his career, Yasushi Shintani has worked with well-known organizations in the pharmaceutical industry, including Takeda Pharmaceutical Company Limited and Takeda Chemical Industries, Inc. His experience in these companies has greatly influenced his research and provided a platform for his innovative ideas.

Collaborations

Shintani has collaborated with notable coworkers, including Takuya Watanabe and Yasuko Terao. These partnerships have enhanced his research efforts and contributed to the development of his patented inventions.

Conclusion

Yasushi Shintani exemplifies the innovative spirit in the pharmaceutical sector. His commitment to tackling age-related diseases through groundbreaking research and collaboration marks him as a key figure in his field. With a growing number of patents, Shintani continues to pave the way for advancements that can significantly improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…